Addiction neuroscience · 2025
Predator scent stress reduces oxycodone self-administration and the nucleus accumbens dopamine response to oxycodone in female rats.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bennett Frances J, Oppat Kailey M, Zaidi Mohammad Y, Winer Joshua, Russell Maria C, Staley Charles, Maithel Shishir K, Concors Seth J
Аннотация
BACKGROUND: Cytoreductive surgery (CRS) with or without heated intraperitoneal chemotherapy (HIPEC) represents a viable therapy for select patients with colorectal cancer (CRC) peritoneal metastases. Given recurrence rates, challenges returning to oncologic treatment postoperatively, and desire to assess tumor biology, neoadjuvant chemotherapy (NAC) is common. Evidence-based guidance regarding NAC duration is limited.
METHODS: A single institution database (2009-2024) of patients with CRC that underwent CRS ± HIPEC was reviewed. Patients undergoing curative intent CRS ± HIPEC with known NAC duration were stratified by NAC duration (0-3 vs > 3 months). Primary outcomes were recurrence-free survival (RFS) and overall survival (OS). Secondary outcome was clinically significant postoperative complications.
RESULTS: From 2009-2024, 87 patients underwent curative intent CRS ± HIPEC (> 3 months NAC: 58 patients, 0-3 months NAC: 29 patients). Median peritoneal cancer index score was similar between cohorts (> 3 months: 11 vs 0-3 months: 12; p = 0.98). RFS and OS were not statistically different based on NAC duration (RFS: > 3 months: 8 months vs 0-3 months: 15 months, p = 0.28) (OS: > 3 months: 26 months vs 0-3 months: 35 months; p = 0.33). > 3 months of NAC was associated with increased median length of stay (> 3 months: 10 days vs 0-3 months: 8 days; p = 0.04). Even when controlling for other perioperative variables on multivariable analysis, > 3 months of NAC was associated with increased risk of clinically significant complications (HR 3.47, 95 % CI 1.11-10.88; p = 0.03).
CONCLUSION: Greater duration of NAC prior to CRS ± HIPEC is not associated with improved RFS or OS, and, rather, is associated with higher complication rate and longer hospital stay.
METHODS: A single institution database (2009-2024) of patients with CRC that underwent CRS ± HIPEC was reviewed. Patients undergoing curative intent CRS ± HIPEC with known NAC duration were stratified by NAC duration (0-3 vs > 3 months). Primary outcomes were recurrence-free survival (RFS) and overall survival (OS). Secondary outcome was clinically significant postoperative complications.
RESULTS: From 2009-2024, 87 patients underwent curative intent CRS ± HIPEC (> 3 months NAC: 58 patients, 0-3 months NAC: 29 patients). Median peritoneal cancer index score was similar between cohorts (> 3 months: 11 vs 0-3 months: 12; p = 0.98). RFS and OS were not statistically different based on NAC duration (RFS: > 3 months: 8 months vs 0-3 months: 15 months, p = 0.28) (OS: > 3 months: 26 months vs 0-3 months: 35 months; p = 0.33). > 3 months of NAC was associated with increased median length of stay (> 3 months: 10 days vs 0-3 months: 8 days; p = 0.04). Even when controlling for other perioperative variables on multivariable analysis, > 3 months of NAC was associated with increased risk of clinically significant complications (HR 3.47, 95 % CI 1.11-10.88; p = 0.03).
CONCLUSION: Greater duration of NAC prior to CRS ± HIPEC is not associated with improved RFS or OS, and, rather, is associated with higher complication rate and longer hospital stay.